BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14697741)

  • 1. An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome.
    Conley ME; Saragoussi D; Notarangelo L; Etzioni A; Casanova JL; ;
    Clin Immunol; 2003 Dec; 109(3):272-7. PubMed ID: 14697741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
    Krisiukeniene A; Sitkauskiene B; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
    Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
    Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report.
    Syrigos KN; Makrilia N; Neidhart J; Moutsos M; Tsimpoukis S; Kiagia M; Saif MW
    Ital J Pediatr; 2011 Sep; 37():42. PubMed ID: 21906397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant and persistent improvement of thrombocytopenia after splenectomy in an adult with the Wiskott-Aldrich Syndrome and intra-cerebral bleeding.
    Gaspoz JM; Waldvogel F; Cornu P; Gugler E; Dayer JM
    Am J Hematol; 1995 Mar; 48(3):182-5. PubMed ID: 7864026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome.
    de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A
    Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634
    [No Abstract]   [Full Text] [Related]  

  • 11. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
    Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
    Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
    Peacocke M; Siminovitch KA
    J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated umbilical cord stem cell transplantation in an eleven-month-old male infant with Wiskott-Aldrich syndrome.
    Chen CY; Chiou YH; Su HW; Chang YH
    Kaohsiung J Med Sci; 2018 Feb; 34(2):122-123. PubMed ID: 29413229
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
    Mathew P; Conley ME
    Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
    Li W; Liu D; Zhang X; Ding Y; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
    Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
    Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.